Biolog Wins $2.5M Phase II NIH SBIR Grant to Develop Tox Applications for Cell Arrays | GenomeWeb

NEW YORK, Oct. 13 (GenomeWeb News) - Biolog has won a $2.5 million phase II SBIR grant from the NIH to further develop its cellular microarray technology, the Hayward, Calif.-based company said today.


Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Familial DNA searches in criminal cases are winning over some critics, the Los Angeles Times reports.

In Nucleic Acids Research this week: ProTraits includes genetic, phenotypic data on bacteria, archaea; Candida albicans assembly 22; and more.

The Wall Street Journal reports that researchers are looking beyond Cas9 for CRISPR editing.

In PNAS this week: miR-515 levels higher in women with preeclampsia, horizontal gene transfer in parasitic plants, and more.